Fibroblast Paracrine TNF-α Signaling Elevates Integrin A5 Expression in Idiopathic Pulmonary Fibrosis (IPF)

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2017 Jun 21

PMID 28629363

Citations 31

Authors

Gali Epstein Shochet

Elizabetha Brook

Lilach Israeli-Shani

Evgeny Edelstein

David Shitrit

Affiliations

Soon will be listed here.

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis. Inflammatory cytokines play a significant role in IPF pathology. However, the fibroblast itself is also believed to be the primary effector in IPF. We hypothesized that the fibroblasts themselves secrete pro-inflammatory cytokines that could propagate IPF by affecting normal neighboring cells. Thus, we explored the effects of IPF fibroblast derived media on normal fibroblast characteristics.

Methods: Primary IPF/normal tissue derived fibroblast cultures were established and their supernatants were collected (IPF/N-SN, respectively). These supernatants were added to normal fibroblasts. Cell death (caspase-3, western blot), proliferation, viability (WST-1), migration (scratch test) and cell detachment (crystal violet and fibronectin adhesion assays) were tested. 10 inflammatory cytokines were measured by ELISA-based quantitative array. Integrin α5 (ITGA5), pIκBα, p/total STAT3 levels were measured by western blot/IHC. TNF-α involvement was confirmed using Infliximab ®, anti-TNF-α mAb.

Results: The IPF-SN facilitated fibroblast cell detachment and reduced cell migration (p < 0.05). Nevertheless, these effects were reversed when cells were seeded on fibronectin. The exposure to the IPF-SN also elevated ITGA5 levels, the fibronectin receptor, in addition to NFκB pathway activation (pIκBα↑ 150%, p < 0.05). In accordance, IPF derived fibroblasts were found to express higher ITGA5 than the normal cells (44%↑, p < 0.05). ITGA5 was also expressed in the fibroblastic foci. The IPF-SN contained high TNF-α levels (3-fold, p < 0.05), and Infliximab pretreatment successfully reversed all the above observations.

Conclusion: We suggest a possible mechanism in which IPF fibroblast secreted TNF-α modifies neighboring fibroblast cell behavior.

Citing Articles

The role of vascularity and the fibrovascular interface in interstitial lung diseases.

Dietrich J, Kang A, Tielemans B, Verleden S, Khalil H, Langer F Eur Respir Rev. 2025; 34(175).

PMID: 39909504 PMC: 11795288. DOI: 10.1183/16000617.0080-2024.

The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer.

Kim K, Khazan N, McDowell J, Snyder C, Miller J, Singh R PLoS One. 2024; 19(12):e0314564.

PMID: 39621651 PMC: 11611113. DOI: 10.1371/journal.pone.0314564.

Prognostic model of fibroblasts in idiopathic pulmonary fibrosis by combined bulk and single-cell RNA-sequencing.

Zhao J, Jing C, Fan R, Zhang W Heliyon. 2024; 10(14):e34519.

PMID: 39113997 PMC: 11305307. DOI: 10.1016/j.heliyon.2024.e34519.

Fibroblast Activation Protein Alpha (FAPα) in Fibrosis: Beyond a Perspective Marker for Activated Stromal Cells?.

Basalova N, Alexandrushkina N, Grigorieva O, Kulebyakina M, Efimenko A Biomolecules. 2023; 13(12).

PMID: 38136590 PMC: 10742035. DOI: 10.3390/biom13121718.

Prostaglandin E2 (PGE2) and Roflumilast Involvement in IPF Progression.

Moshkovitz N, Epstein Shochet G, Shitrit D Int J Mol Sci. 2023; 24(15).

PMID: 37569768 PMC: 10418473. DOI: 10.3390/ijms241512393.

References

Li B, Pozzi A, Young P . TNFalpha accelerates monocyte to endothelial transdifferentiation in tumors by the induction of integrin alpha5 expression and adhesion to fibronectin. Mol Cancer Res. 2011; 9(6):702-11. PMC: 3157289. DOI: 10.1158/1541-7786.MCR-10-0484. View

Katzenstein A, Myers J . Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998; 157(4 Pt 1):1301-15. DOI: 10.1164/ajrccm.157.4.9707039. View

Raghu G, Brown K, Costabel U, Cottin V, du Bois R, Lasky J . Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med. 2008; 178(9):948-55. DOI: 10.1164/rccm.200709-1446OC. View

Verjee L, Verhoekx J, Chan J, Krausgruber T, Nicolaidou V, Izadi D . Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target. Proc Natl Acad Sci U S A. 2013; 110(10):E928-37. PMC: 3593900. DOI: 10.1073/pnas.1301100110. View

Attar-Schneider O, Zismanov V, Drucker L, Gottfried M . Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation. Tumour Biol. 2015; 37(4):4755-65. DOI: 10.1007/s13277-015-4304-3. View

Kowalczuk O, Burzykowski T, Niklinska W, Kozlowski M, Chyczewski L, Niklinski J . CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. Tumour Biol. 2014; 35(5):4619-28. PMC: 4009141. DOI: 10.1007/s13277-014-1605-x. View

Larsson O, Diebold D, Fan D, Peterson M, Nho R, Bitterman P . Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One. 2008; 3(9):e3220. PMC: 2528966. DOI: 10.1371/journal.pone.0003220. View

Vancheri C, Failla M, Crimi N, Raghu G . Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010; 35(3):496-504. DOI: 10.1183/09031936.00077309. View

Almeida M, Monteiro K, Kato E, Sampaio S, Braga T, Camara N . Hyperglycemia reduces integrin subunits alpha v and alpha 5 on the surface of dermal fibroblasts contributing to deficient migration. Mol Cell Biochem. 2016; 421(1-2):19-28. DOI: 10.1007/s11010-016-2780-4. View

10.

Richeldi L, DAVIES H, Ferrara G, Franco F . Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev. 2003; (3):CD002880. PMC: 8457302. DOI: 10.1002/14651858.CD002880. View

11.

Tsoutsou P, Gourgoulianis K, Petinaki E, Germenis A, Tsoutsou A, Mpaka M . Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Respir Med. 2005; 100(5):938-45. DOI: 10.1016/j.rmed.2005.06.016. View

12.

Epstein Shochet G, Israeli-Shani L, Koslow M, Shitrit D . Nintedanib (BIBF 1120) blocks the tumor promoting signals of lung fibroblast soluble microenvironment. Lung Cancer. 2016; 96:7-14. DOI: 10.1016/j.lungcan.2016.03.013. View

13.

Sime P, Marr R, Gauldie D, Xing Z, Hewlett B, Graham F . Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. Am J Pathol. 1998; 153(3):825-32. PMC: 1853002. DOI: 10.1016/s0002-9440(10)65624-6. View

14.

Scallon B, Cai A, Solowski N, Rosenberg A, Song X, Shealy D . Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther. 2002; 301(2):418-26. DOI: 10.1124/jpet.301.2.418. View

15.

Alhamad E, Cal J, Shakoor Z, Almogren A, AlBoukai A . Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis. BMC Med Genet. 2013; 14:66. PMC: 3700855. DOI: 10.1186/1471-2350-14-66. View

16.

Baglole C, Reddy S, Pollock S, Feldon S, Sime P, Smith T . Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med. 2005; 117:115-27. DOI: 10.1385/1-59259-940-0:115. View

17.

Wynn T . Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011; 208(7):1339-50. PMC: 3136685. DOI: 10.1084/jem.20110551. View

18.

Todd N, Luzina I, Atamas S . Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair. 2012; 5(1):11. PMC: 3443459. DOI: 10.1186/1755-1536-5-11. View

19.

Locksley R, Killeen N, Lenardo M . The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104(4):487-501. DOI: 10.1016/s0092-8674(01)00237-9. View

20.

Lopez-Novoa J, Nieto M . Inflammation and EMT: an alliance towards organ fibrosis and cancer progression. EMBO Mol Med. 2010; 1(6-7):303-14. PMC: 3378143. DOI: 10.1002/emmm.200900043. View